Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

FOUNDATION MEDICINE SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Foundation Medicine, Inc. - (FMI)

ClaimsFiler
Posted on: 26 Aug 17

PR Newswire

NEW ORLEANS, Aug. 25, 2017

NEW ORLEANS, Aug. 25, 2017 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have untilSeptember 26, 2017 to file lead plaintiff applications in a securities class action lawsuit against Foundation Medicine, Inc. (NasdaqGS: FMI), if they purchased the Company's shares between February 26, 2014 and November 3, 2015, inclusive (the "Class Period").  This action is pending in the United States District Court for the District of Massachusetts.

Get Help

Foundation Medicine, Inc. investors should visit us for more information about their rights at https://www.claimsfiler.com/cases/view-foundation-medicine-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.  

About the Lawsuit

Foundation Medicine and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the likelihood that the Company would be approved for reimbursement of its tumor tests by Medicare; (ii) the Company's progress in doing so; (iii) the Company's robust 2015 financial guidance; (iv) the assumption of Medicare approval on which its 2015 guidance was based; and (iv) as a result of the foregoing, Foundation's financial statements were materially false and misleading at all relevant times.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

 

View original content:http://www.prnewswire.com/news-releases/foundation-medicine-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-foundation-medicine-inc---fmi-300509863.html

SOURCE ClaimsFiler

PR Newswire
www.prnewswire.com

Last updated on: 26/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.